Understanding Joint Commission 360 Standards: What They Mean for SPD Teams (Part 2)
Healthcare teams today are feeling the pressure to move beyond last-minute compliance and instead build processes that work consistently every day. That shift is especially clear in sterile processing departments (SPDs), where the Joint Commission 360 model is redefining what “survey readiness” really means. With patient safety directly tied to instrument quality—and studies consistently linking process variability to surgical risk—the stakes for getting SPD workflows right have never been higher.
So what does it actually look like for SPD teams to move from reactive compliance to a culture of continuous readiness—and can they do it without burning out their staff?
That’s the question at the heart of this episode of ConCensis. Host Daniel Litwin sits down with Dr. Ivan Salgo, Chief Medical Officer at Censis and ASP, and Sabrina M. Ford, Market Manager of Central Sterilization at CommonSpirit. Together, they unpack how Joint Commission 360 standards are transforming SPD workflows, leadership expectations, and the role of technology in sustaining compliance—building on key themes introduced in the first part of the conversation.
Top insights from the talk…
- From reactive to proactive compliance: Teams must embed standards into daily workflows—“stay ready so you don’t have to get ready”—eliminating last-minute audit stress.
- Data and visibility drive accountability: Instrument tracking systems, KPI dashboards, and real-time documentation are essential for identifying gaps and sustaining performance.
- Culture and leadership alignment are critical: True transformation requires engagement from frontline staff to the C-suite, shifting SPD into a strategic clinical partner role.
Dr. Ivan Salgo is a physician-executive and Chief Medical Officer at Advanced Sterilization Products (ASP)/Fortive, with extensive leadership experience across medical devices, life sciences, and healthcare technology, spanning R&D, clinical affairs, regulatory strategy, and commercialization. He has led breakthrough innovations—from NIH-funded research to global market leadership—including key contributions to Philips Live 3DTEE and significant growth in cardiology ultrasound, and is recognized for shaping strategy and accelerating adoption of high-impact clinical technologies.
Sabrina M. Ford is the Market Manager of Central Sterilization at CommonSpirit Health, where she leads SPD strategy and operations across multiple facilities. Known for her focus on Lean principles, staff competency development, and operational discipline, Ford has been instrumental in advancing continuous readiness models within large health systems. In her role, she also emphasizes team accountability, data visibility, and standardized workflows to support consistent survey readiness and performance improvement.
Article written by MarketScale.
